A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models
Rebecca Jane Cox(Haukeland University Hospital), John Wood(Women's and Children's Hospital), Lars R. Haaheim(University of Bergen), Maria Zambon(Public Health England), Abdullah S. Madhun(Norwegian Institute of Marine Research), Karl A. Brokstad(Western Norway University of Applied Sciences), Mirjam Kühne, Jon Smith(Sanofi (France)), Solveig Hauge(University of Bergen), Diane Major(National Institute for Biological Standards and Control), Frederick R. Vogel(Sanofi (France))
Cited by 34
Related Papers
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
|Journal of Clinical Investigation|2008|349